1. Bhaskaran K, Dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol. déc 2018;6(12):944‑53. doi:10.1016/S2213-8587(18)30288-2 PubMed PMID: 30389323; PubMed Central PMCID: PMC6249991.

2. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery. N Engl J Med. 23 déc 2004;351(26):2683‑93. doi:10.1056/NEJMoa035622

3. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 23 août 2007;357(8):741‑52. doi:10.1056/NEJMoa066254 PubMed PMID: 17715408.

Carlsson LMS, Sjöholm K, Jacobson P, Andersson-Assarsson JC, Svensson PA, Taube M, et al. Life expectancy after bariatric surgery in the Swedish obese subjects study. N Engl J Med. 2020;383(16):1535–43. https://doi.org/10.1056/NEJMoa2002449.

Article  PubMed  PubMed Central  Google Scholar 

5. Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery. OBES SURG. janv 2023;33(1):3‑14. doi:10.1007/s11695-022-06332-1

6. Gul D, Khan AW, Butt MA, Suheb MK, Sartaj S, Chabria S, et al. Clinical outcomes of roux-en-Y gastric bypass versus medical therapy in type 2 diabetes mellitus: a systematic review and meta-analysis. J Diabetes Metab Disord. 10 janv 2025;24(1):43. doi:10.1007/s40200-024-01526-z

7. Ugale S, Gupta N, Modi KD, Kota SK, Satwalekar V, Naik V, et al. Prediction of remission after metabolic surgery using a novel scoring system in type 2 diabetes – a retrospective cohort study. J Diabetes Metab Disord. 22 août 2014;13(1):89. doi:10.1186/s40200-014-0089-y

8. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 26 avr 2012;366(17):1577‑85. doi:10.1056/NEJMoa1200111 PubMed PMID: 22449317.

9. Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KGMM, Zimmet PZ, et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations. Obes Surg. janv 2017;27(1):2‑21. doi:10.1007/s11695-016-2457-9 PubMed PMID: 27957699.

Courcoulas AP, Belle SH, Neiberg RH, Pierson SK, Eagleton JK, Kalarchian MA, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg. 2015;150(10):931. https://doi.org/10.1001/jamasurg.2015.1534.

Article  CAS  PubMed  PubMed Central  Google Scholar 

11. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, et al. Bariatric surgery versus intensive medical therapy for diabetes–3-year outcomes. N Engl J Med. 22 mai 2014;370(21):2002‑13. doi:10.1056/NEJMoa1401329 PubMed PMID: 24679060; PubMed Central PMCID: PMC5451259.

12. Ikramuddin S, Korner J, Lee WJ, Thomas AJ, Connett JE, Bantle JP, et al. Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study. JAMA. 16 janv 2018;319(3):266. doi:10.1001/jama.2017.20813

13. Courcoulas AP, Gallagher JW, Neiberg RH, Eagleton EB, DeLany JP, Lang W, et al. Bariatric Surgery vs Lifestyle Intervention for Diabetes Treatment: 5-Year Outcomes From a Randomized Trial. The Journal of Clinical Endocrinology & Metabolism. 1 mars 2020;105(3):866‑76. doi:10.1210/clinem/dgaa006

14. HAS. Metabolic surgery : surgical treatment of type 2 diabetes. Assessement report 6 october 2022. Available on https://www.has-sante.fr/upload/docs/application/pdf/2022-12/rapport_chir_metabo_vd_en.pdf.

15. Charles MA. [Update on the epidemiology of obesity and type 2 diabetes in France]. Diabetes Metab. juin 2000;26 Suppl 3:17‑20. PubMed PMID: 10945146.

16. Sarwer DB, Ritter S, Wadden TA, Spitzer JC, Vetter ML, Moore RH. Physicians’ attitudes about referring their type 2 diabetes patients for bariatric surgery. Surgery for Obesity and Related Diseases. juill 2012;8(4):381‑6. doi:10.1016/j.soard.2011.12.013

17. Holmes S, Sarma S, Campbell S, Azab A, Qiang J, Mukerji G. Gaps in Referral to Bariatric Surgery for Patients With Type 2 Diabetes Seen in Endocrinology Clinics. Canadian Journal of Diabetes. déc 2022;46(8):835–842.e1. doi:10.1016/j.jcjd.2022.06.005

18. Davies MJ, Bergenstal R, Bode B, Kushner RF, Lewin A, Skjøth TV, et al. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial. JAMA. 18 août 2015;314(7):687. doi:10.1001/jama.2015.9676

19. Davies M, Færch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L, et al. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet. mars 2021;397(10278):971‑84. doi:10.1016/S0140-6736(21)00213-0

20. Garvey WT, Frias JP, Jastreboff AM, Le Roux CW, Sattar N, Aizenberg D, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet. août 2023;402(10402):613‑26. doi:10.1016/S0140-6736(23)01200-X

21. Modi AC, Zeller MH, Xanthakos SA, Jenkins TM, Inge TH. Adherence to vitamin supplementation following adolescent bariatric surgery. Obesity. mars 2013;21(3). doi:10.1002/oby.20031

22. Sillo TO, Lloyd-Owen S, White E, Abolghasemi-Malekabadi K, Lock-Pullan P, Ali M, et al. The impact of bariatric surgery on the resolution of obstructive sleep apnoea. BMC Res Notes. déc 2018;11(1):385. doi:10.1186/s13104-018-3484-5